ADHD Medication Changes Behavior, Not Learning
Barkley likens ADHD to diabetes, yet 64% of people cycle back out of the diagnostic criteria; medication improves compliance but not learning, and the MTA long-term follow-up confirms no academic advantage — what actually works is small-group differentiated instruction.
The video won't play here. Listen to the audio instead:
The argument · timestamps estimated from transcript position
His own data refute his own metaphor
Barkley has long likened ADHD to diabetes and argued it requires lifelong treatment. But in his own follow-up study, 64% of children showed a markedly fluctuating course, cycling out of and back into the diagnostic criteria. The host points out: diabetes doesn't do that — a pancreas doesn't work normally for a few years and then fail, you don't cycle out of a diabetes diagnosis. If ADHD really were a biological defect of the brain, this kind of "coming and going" shouldn't happen. Yet Barkley then still insists that over 90% have high symptoms for life. The two claims are in direct logical contradiction.
— Jen LumanlanKids' self-reports differ from parents' by 10x
In Barkley's Milwaukee study, at age 21 only 4% of participants reported enough symptoms in the diagnostic interview, while at the same time the proportion reported by parents was 46% — a 10-fold gap. Barkley explains the difference as young people underestimating their own symptoms, and says their reports don't become reliable until around age 30. The host offers another reading: why couldn't it be that parents overestimate? The diagnostic process never really asked the child about their experience in the first place. So the 4% figure may be exactly the result of a diagnostic system that doesn't trust children.
— Jen LumanlanDiagnosis asks how much trouble the child causes parents
In the textbook Barkley edited, the questions in the child diagnostic interview include "what does your child do that bothers you" and "how severe is this for you," rated 1 to 9. The subject of the questions is the degree to which parents are affected by the child's behavior, not the child's own feelings. The same textbook also concedes that symptoms vary with context: high activity during recess is normal, and only becomes a problem back in the classroom. The host asks: if the child is simply unsuited to a motionless classroom environment, why is the disease located in the child rather than in the environment?
— Jen LumanlanDrugs let people show what they know, not learn new things
Barkley states plainly that the premise for using stimulants is that they "work," and that their function is to help an individual perform knowledge they already have, not to increase the amount of knowledge. The host seizes on this logic: if medication only lets what is already known be performed, short-term academic scores shouldn't rise in the first place; and if you expect the amount of knowledge to increase after long-term medication, Barkley then complains that existing academic studies are too short to capture long-term gains. She also notes that pharmaceutical companies don't advertise long-term academic gains — which is itself a negative signal.
— Jen LumanlanThe same kids didn't learn one more word on medication
The Pelham study used a crossover design in which 173 children with ADHD studied social studies, science, and vocabulary units under medication and under placebo. Medication had a huge effect on classroom behavior: 37% more arithmetic problems completed per minute, 53% fewer rule violations per hour — they looked like model students. But knowledge tests showed they didn't learn more content on medication than on placebo, and memory didn't improve either. Medication had only a small effect on immediate test scores within the window of drug efficacy, and it vanished once the drug wore off — a performance effect, not a learning effect.
— Jen LumanlanWhat actually gets kids learning is small classes
The host concedes Barkley would say Pelham's classroom isn't the real world, but also points out the key: in those small classes (1 to 11 per group, averaging 5 to 6), using evidence-based strategies like brainstorming, think-pair-share, modeling aloud, and having students summarize and predict, the children did learn. Medication added no learning effect on top of good teaching. This becomes a resource question: put the funding into the classroom, or keep buying drugs? Medication can raise compliance, but it can't deliver the learning outcomes parents actually want.
— Jen LumanlanBarkley opposes kids taking part in medication decisions
Confronted with the proposal that children should take part in medication decisions, Barkley says children have no frontal lobe, no capacity to weigh pros and cons, and that giving children a say is "incredible, utterly absurd." But children describe the experience of taking the medication themselves as: headaches, depression, friends saying I'm not me anymore, becoming boring, nausea, can't eat. The medical model demands lifelong use like insulin, with the child having no say — and the person actually bearing the side effects every day is precisely the child.
— Dr. Barkley / Jen LumanlanFive years on, 80% of kids have stopped
Discontinuation studies show that one year after starting medication only 40% to 60% are still taking it; among those over 12 about half, slightly higher for ages 4 to 11 because parents are pushing it. After five years only 20% of the child group remains, and only about 10% of the older group. These discontinuation rates are far higher than the natural remission rate of ADHD symptoms, suggesting people stop not because the condition improved, but because children dislike how the drug feels, or don't believe it helps with things they care about. This directly rebuts the lifelong-medication narrative.
— Jen LumanlanIn their own words · checked verbatim
the majority of children in this study, 64% showed a markedly fluctuating course moving out of the diagnostic criteria
Dr. Barkley6:20
only about 4% reported enough symptoms to be diagnosed as ADHD in adulthood. However, if we interviewed your parents at that same follow-up period at age 21, the rate of disorder was 10 times higher
Dr. Barkley9:12
The use of medication for ADHD is predicated on one premise: it works.
Dr. Barkley16:09
It was a performance effect, not a learning effect.
Jen Lumanlan18:49
Medication did not make them learn more, but good teaching did.
Jen Lumanlan23:28
The idea that we would allow the child to make these decisions on their own or even to have a voice in these decisions is incredible. I mean, it's ludicrous.
Dr. Barkley25:17
Maybe they understand that sitting still and completing worksheets is not the same as learning and that being compliant is not the same as thriving.
Jen Lumanlan27:35
Figures
| Share of ADHD children in the study showing a markedly fluctuating course | 64% | 6:20 |
| Share self-reporting they met ADHD diagnostic criteria at age 21 | 4% | 9:12 |
| Share of the same age-21 sample whose parents reported they met criteria | 46% (10 times the self-report) | 9:12 |
| Increase in arithmetic problems completed per minute while on medication | 37% | 18:49 |
| Reduction in rule violations per hour while on medication | 53% | 18:49 |
| Number followed up in the MTA study | 538 children | 16:09 |
| Average daily dose increase among those who stayed on medication in the MTA | 41% | 16:09 |
| Share still on medication one year after starting | 40-60% | 26:24 |
| Share of children still on medication five years after starting | 20% | 26:24 |
| Share of the older group still on medication five years after starting | about 10% | 26:24 |
Glossary
- MTA study
- The largest randomized controlled trial of ADHD treatment to date, with 6- to 8-year follow-up.
- crossover design
- The same subjects receive medication and placebo in sequence, each serving as their own control.
- DSM
- The diagnostic manual published by the American Psychiatric Association; ADHD's 18 symptoms come from it.
- misrecognition
- A concept proposed by ADHD researcher Andrew Ivan Brown, referring to ADHDers being wrongly defined from the outside; covered in detail in the next episode.
How to listen
Parents still weighing whether to medicate their child, teachers who want to get the classroom environment right, and clinicians concerned with the evidence on pediatric psychiatric medication.
The roughly minute-and-a-half show ad at the open and the subscription pitch at the end can be skipped.